首頁 > 市場調查報告書 > 醫療設備

體外診斷

市場調查報告書

商品編碼

1922443

日本藥物篩檢市場報告：按產品/服務、檢體類型、最終用戶和地區分類，2026-2034年

Japan Drug Screening Market Report by Product and Service, Sample Type, End User, and Region 2026-2034

出版日期: 2026年01月01日 | 出版商:

IMARC | 英文 120 Pages | 商品交期: 5-7個工作天內

價格

簡介目錄

2025年，日本藥物篩檢市場規模達4.644億美元。 IMARC Group預測，到2034年，該市場規模將達到14.614億美元，2026年至2034年的複合年成長率（CAGR）為13.59%。推動該市場成長的關鍵因素包括：毒品販運者和本地毒販活動的增加、毒品濫用案件的激增以及虛擬貨幣的日益普及。

藥物篩檢是指採集並檢測個人血液、尿液、毛髮或唾液樣本，以識別是否有指示藥物使用的物質或化學物質。該過程涉及多種檢測方法，包括酵素免疫分析法(EIA)、氣相層析法(GC) 和液相層析法/質譜聯用 (LC/MS)。特別是 LC/MS，被認為是一種優秀的、高度準確的確認性檢測方法，可用於初次檢測呈陽性後進行確認。其主要目的是檢測合法和非法藥物的使用情況，包括可卡因、海洛因和 3,4-亞甲基安非他命(MDMA) 等非法物質。它也用於識別處方藥的濫用情況，這些濫用通常以不同的方式服用或過量服用。藥物篩檢在評估新藥療效和安全性的臨床試驗中發揮重要作用。它也是刑事執法程序的重要組成部分。此外，它還有助於評估接受鴉片類藥物治療的患者的潛在濫用風險和藥物順從性。

日本藥物篩檢市場趨勢：

受多種因素影響，日本藥物篩檢市場目前正經歷顯著成長。其中，關鍵促進因素是各應用領域對準確快速檢測結果的需求不斷成長。此外，隨著社會面臨成癮的挑戰，藥物濫用案件的增加也成為市場擴張的主要動力。另一個促進市場成長的因素是，人們普遍使用藥物來應對壓力、焦慮和生活困境，這進一步凸顯了有效藥物篩檢的必要性。此外，政府機構也發揮關鍵作用，實施常規路邊口腔液篩檢以檢測受藥物影響的駕駛員，並啟動藥物濫用和成癮預防計畫以滿足成癮的需求。此外，加密貨幣的使用為買賣雙方提供了匿名性，也助長了毒販和本地經銷商的活動，從而推動了市場推出。這些因素共同作用，將使日本藥物篩檢市場在預測期內保持積極前景。

本報告解答的關鍵問題

日本藥物篩檢市場目前表現如何？未來幾年又將如何發展？
新冠疫情對日本藥物篩檢市場感染疾病了哪些影響？
日本藥物篩檢市場按產品和服務分類的組成是什麼？
日本藥物篩檢市場依樣本類型分類的組成是怎樣的？
日本藥物篩檢市場依最終用戶分類的組成是怎樣的？
日本藥物篩檢市場價值鏈的不同階段有哪些？
日本藥物篩檢的主要促進因素和挑戰是什麼？
日本藥物篩檢市場的結構是怎麼樣的？主要參與者有哪些？
日本的藥物篩檢市場競爭有多激烈？

Japan drug screening market size reached USD 464.4 Million in 2025 . Looking forward, IMARC Group expects the market to reach USD 1,461.4 Million by 2034 , exhibiting a growth rate (CAGR) of 13.59% during 2026-2034 . The market is being propelled by several significant factors, including the escalating presence of drug traffickers and local dealers, a surge in substance abuse cases, and the growing utilization of virtual currencies.

Access the full market insights report Request Sample

Drug screening involves the procedure of collecting and examining an individual's blood, urine, hair, or saliva to identify the presence of substances and chemicals indicative of drug use. This process encompasses a wide array of testing methods, including enzyme immunoassays (IAs), gas chromatography (GC), and liquid chromatography/mass spectrometry (LC/MS), which is considered a superior and highly precise confirmation test utilized when initial results show positive. Its primary purpose is to detect both the legitimate and illegitimate use of drugs, spanning illegal substances like cocaine, heroin, and 3,4-Methylenedioxymethamphetamine (MDMA). Additionally, it is employed to identify the misuse of various prescription medications when they are consumed differently or in excessive quantities. Drug screening plays a crucial role in clinical trials for evaluating the effectiveness and safety of novel drugs. Moreover, it is an essential component in legal proceedings, serving the purposes of criminal law enforcement. Furthermore, it aids in assessing the potential for abuse and adherence among patients receiving opioid therapy.

JAPAN DRUG SCREENING MARKET TRENDS:

The Japan drug screening market is currently experiencing significant growth driven by a multitude of influential factors. Foremost among these factors is the rising demand for drug screening due to its accuracy and the rapid delivery of results, making it an appealing choice for various applications. Moreover, the increase in cases of substance abuse is a key driver of market expansion, as societies grapple with the challenges of addiction and its consequences. Another factor contributing to the market's growth is the growing prevalence of drug use as a coping mechanism for stress, anxiety, and life's hardships, further emphasizing the need for effective drug screening. Additionally, government agencies are also playing a pivotal role by initiating regular roadside oral fluid screening to detect drug-impaired drivers and launching substance abuse and addiction programs to address the needs of addicts. Furthermore, the presence of drug traffickers and local dealers, facilitated by the use of virtual currencies that offer anonymity to buyers and sellers, is supporting the market's expansion. These factors will collectively contribute to the positive outlook for the drug screening market in Japan over the forecasted period.

JAPAN DRUG SCREENING MARKET SEGMENTATION:

Product and Service Insights:

To get detailed segment analysis of this market Request Sample
Equipment Immunoassay Analyzers Chromatography Instruments Breath Analyzers
Immunoassay Analyzers
Chromatography Instruments
Breath Analyzers
Rapid Testing Devices Urine Testing Devices Oral Fluid Testing Devices
Urine Testing Devices
Oral Fluid Testing Devices
Consumables Assay Kits Sample Collection Cups Calibrators and Controls Others
Assay Kits
Sample Collection Cups
Calibrators and Controls
Others
Laboratory Services
Equipment Immunoassay Analyzers Chromatography Instruments Breath Analyzers
Immunoassay Analyzers
Chromatography Instruments
Breath Analyzers
Immunoassay Analyzers
Chromatography Instruments
Breath Analyzers
Immunoassay Analyzers
Chromatography Instruments
Breath Analyzers
Rapid Testing Devices Urine Testing Devices Oral Fluid Testing Devices
Urine Testing Devices
Oral Fluid Testing Devices
Urine Testing Devices
Oral Fluid Testing Devices
Urine Testing Devices
Oral Fluid Testing Devices
Consumables Assay Kits Sample Collection Cups Calibrators and Controls Others
Assay Kits
Sample Collection Cups
Calibrators and Controls
Others
Assay Kits
Sample Collection Cups
Calibrators and Controls
Others
Assay Kits
Sample Collection Cups
Calibrators and Controls
Others
Laboratory Services

Sample Type Insights:

Urine Samples
Breath Samples
Oral Fluid Samples
Hair Samples
Others
Urine Samples
Breath Samples
Oral Fluid Samples
Hair Samples
Others

End User Insights:

Hospitals
Drug Testing Laboratories
Workplaces
Drug Treatment Centers
Pain Management Centers
Personal Users
Criminal Justice System and Law Enforcement Agencies
Hospitals
Drug Testing Laboratories
Workplaces
Drug Treatment Centers
Pain Management Centers
Personal Users
Criminal Justice System and Law Enforcement Agencies

Regional Insights:

To get detailed regional analysis of this market Request Sample
Kanto Region
Kansai/Kinki Region
Central/ Chubu Region
Kyushu-Okinawa Region
Tohoku Region
Chugoku Region
Hokkaido Region
Shikoku Region
Kanto Region
Kansai/Kinki Region
Central/ Chubu Region
Kyushu-Okinawa Region
Tohoku Region
Chugoku Region
Hokkaido Region
Shikoku Region
The report has also provided a comprehensive analysis of all the major regional markets, which include Kanto Region, Kansai/Kinki Region, Central/ Chubu Region, Kyushu-Okinawa Region, Tohoku Region, Chugoku Region, Hokkaido Region, and Shikoku Region.

COMPETITIVE LANDSCAPE:

The market research report has also provided a comprehensive analysis of the competitive landscape in the market. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

KEY QUESTIONS ANSWERED IN THIS REPORT
How has the Japan drug screening market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the Japan drug screening market?
What is the breakup of the Japan drug screening market on the basis of product and service?
What is the breakup of the Japan drug screening market on the basis of sample type?
What is the breakup of the Japan drug screening market on the basis of end user?
What are the various stages in the value chain of the Japan drug screening market?
What are the key driving factors and challenges in the Japan drug screening?
What is the structure of the Japan drug screening market and who are the key players?
What is the degree of competition in the Japan drug screening market?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Japan Drug Screening Market - Introduction

4.1 Overview
4.2 Market Dynamics
4.3 Industry Trends
4.4 Competitive Intelligence

5 Japan Drug Screening Market Landscape

5.1 Historical and Current Market Trends (2020-2025)
5.2 Market Forecast (2026-2034)

6 Japan Drug Screening Market - Breakup by Product and Service

6.1 Equipment
- 6.1.1 Overview
- 6.1.2 Historical and Current Market Trends (2020-2025)
- 6.1.3 Market Segmentation
  - 6.1.3.1 Immunoassay Analyzers
  - 6.1.3.2 Chromatography Instruments
  - 6.1.3.3 Breath Analyzers
- 6.1.4 Market Forecast (2026-2034)
6.2 Rapid Testing Devices
- 6.2.1 Overview
- 6.2.2 Historical and Current Market Trends (2020-2025)
- 6.2.3 Market Segmentation
  - 6.2.3.1 Urine Testing Devices
  - 6.2.3.2 Oral Fluid Testing Devices
- 6.2.4 Market Forecast (2026-2034)
6.3 Consumables
- 6.3.1 Overview
- 6.3.2 Historical and Current Market Trends (2020-2025)
- 6.3.3 Market Segmentation
  - 6.3.3.1 Assay Kits
  - 6.3.3.2 Sample Collection Cups
  - 6.3.3.3 Calibrators and Controls
  - 6.3.3.4 Others
- 6.3.4 Market Forecast (2026-2034)
6.4 Laboratory Services
- 6.4.1 Overview
- 6.4.2 Historical and Current Market Trends (2020-2025)
- 6.4.3 Market Forecast (2026-2034)

7 Japan Drug Screening Market - Breakup by Sample Type

7.1 Urine Samples
- 7.1.1 Overview
- 7.1.2 Historical and Current Market Trends (2020-2025)
- 7.1.3 Market Forecast (2026-2034)
7.2 Breath Samples
- 7.2.1 Overview
- 7.2.2 Historical and Current Market Trends (2020-2025)
- 7.2.3 Market Forecast (2026-2034)
7.3 Oral Fluid Samples
- 7.3.1 Overview
- 7.3.2 Historical and Current Market Trends (2020-2025)
- 7.3.3 Market Forecast (2026-2034)
7.4 Hair Samples
- 7.4.1 Overview
- 7.4.2 Historical and Current Market Trends (2020-2025)
- 7.4.3 Market Forecast (2026-2034)
7.5 Others
- 7.5.1 Historical and Current Market Trends (2020-2025)
- 7.5.2 Market Forecast (2026-2034)

8 Japan Drug Screening Market - Breakup by End User

8.1 Hospitals
- 8.1.1 Overview
- 8.1.2 Historical and Current Market Trends (2020-2025)
- 8.1.3 Market Forecast (2026-2034)
8.2 Drug Testing Laboratories
- 8.2.1 Overview
- 8.2.2 Historical and Current Market Trends (2020-2025)
- 8.2.3 Market Forecast (2026-2034)
8.3 Workplaces
- 8.3.1 Overview
- 8.3.2 Historical and Current Market Trends (2020-2025)
- 8.3.3 Market Forecast (2026-2034)
8.4 Drug Treatment Centers
- 8.4.1 Overview
- 8.4.2 Historical and Current Market Trends (2020-2025)
- 8.4.3 Market Forecast (2026-2034)
8.5 Pain Management Centers
- 8.5.1 Overview
- 8.5.2 Historical and Current Market Trends (2020-2025)
- 8.5.3 Market Forecast (2026-2034)
8.6 Personal Users
- 8.6.1 Overview
- 8.6.2 Historical and Current Market Trends (2020-2025)
- 8.6.3 Market Forecast (2026-2034)
8.7 Criminal Justice System and Law Enforcement Agencies
- 8.7.1 Overview
- 8.7.2 Historical and Current Market Trends (2020-2025)
- 8.7.3 Market Forecast (2026-2034)

9 Japan Drug Screening Market - Breakup by Region

9.1 Kanto Region
- 9.1.1 Overview
- 9.1.2 Historical and Current Market Trends (2020-2025)
- 9.1.3 Market Breakup by Product and Service
- 9.1.4 Market Breakup by Sample Type
- 9.1.5 Market Breakup by End User
- 9.1.6 Key Players
- 9.1.7 Market Forecast (2026-2034)
9.2 Kansai/Kinki Region
- 9.2.1 Overview
- 9.2.2 Historical and Current Market Trends (2020-2025)
- 9.2.3 Market Breakup by Product and Service
- 9.2.4 Market Breakup by Sample Type
- 9.2.5 Market Breakup by End User
- 9.2.6 Key Players
- 9.2.7 Market Forecast (2026-2034)
9.3 Central/ Chubu Region
- 9.3.1 Overview
- 9.3.2 Historical and Current Market Trends (2020-2025)
- 9.3.3 Market Breakup by Product and Service
- 9.3.4 Market Breakup by Sample Type
- 9.3.5 Market Breakup by End User
- 9.3.6 Key Players
- 9.3.7 Market Forecast (2026-2034)
9.4 Kyushu-Okinawa Region
- 9.4.1 Overview
- 9.4.2 Historical and Current Market Trends (2020-2025)
- 9.4.3 Market Breakup by Product and Service
- 9.4.4 Market Breakup by Sample Type
- 9.4.5 Market Breakup by End User
- 9.4.6 Key Players
- 9.4.7 Market Forecast (2026-2034)
9.5 Tohoku Region
- 9.5.1 Overview
- 9.5.2 Historical and Current Market Trends (2020-2025)
- 9.5.3 Market Breakup by Product and Service
- 9.5.4 Market Breakup by Sample Type
- 9.5.5 Market Breakup by End User
- 9.5.6 Key Players
- 9.5.7 Market Forecast (2026-2034)
9.6 Chugoku Region
- 9.6.1 Overview
- 9.6.2 Historical and Current Market Trends (2020-2025)
- 9.6.3 Market Breakup by Product and Service
- 9.6.4 Market Breakup by Sample Type
- 9.6.5 Market Breakup by End User
- 9.6.6 Key Players
- 9.6.7 Market Forecast (2026-2034)
9.7 Hokkaido Region
- 9.7.1 Overview
- 9.7.2 Historical and Current Market Trends (2020-2025)
- 9.7.3 Market Breakup by Product and Service
- 9.7.4 Market Breakup by Sample Type
- 9.7.5 Market Breakup by End User
- 9.7.6 Key Players
- 9.7.7 Market Forecast (2026-2034)
9.8 Shikoku Region
- 9.8.1 Overview
- 9.8.2 Historical and Current Market Trends (2020-2025)
- 9.8.3 Market Breakup by Product and Service
- 9.8.4 Market Breakup by Sample Type
- 9.8.5 Market Breakup by End User
- 9.8.6 Key Players
- 9.8.7 Market Forecast (2026-2034)

10 Japan Drug Screening Market - Competitive Landscape

10.1 Overview
10.2 Market Structure
10.3 Market Player Positioning
10.4 Top Winning Strategies
10.5 Competitive Dashboard
10.6 Company Evaluation Quadrant

11 Profiles of Key Players

11.1 Company A
- 11.1.1 Business Overview
- 11.1.2 Product Portfolio
- 11.1.3 Business Strategies
- 11.1.4 SWOT Analysis
- 11.1.5 Major News and Events
11.2 Company B
- 11.2.1 Business Overview
- 11.2.2 Product Portfolio
- 11.2.3 Business Strategies
- 11.2.4 SWOT Analysis
- 11.2.5 Major News and Events
11.3 Company C
- 11.3.1 Business Overview
- 11.3.2 Product Portfolio
- 11.3.3 Business Strategies
- 11.3.4 SWOT Analysis
- 11.3.5 Major News and Events
11.4 Company D
- 11.4.1 Business Overview
- 11.4.2 Product Portfolio
- 11.4.3 Business Strategies
- 11.4.4 SWOT Analysis
- 11.4.5 Major News and Events
11.5 Company E
- 11.5.1 Business Overview
- 11.5.2 Product Portfolio
- 11.5.3 Business Strategies
- 11.5.4 SWOT Analysis
- 11.5.5 Major News and Events

12 Japan Drug Screening Market - Industry Analysis

12.1 Drivers, Restraints, and Opportunities
- 12.1.1 Overview
- 12.1.2 Drivers
- 12.1.3 Restraints
- 12.1.4 Opportunities
12.2 Porters Five Forces Analysis
- 12.2.1 Overview
- 12.2.2 Bargaining Power of Buyers
- 12.2.3 Bargaining Power of Suppliers
- 12.2.4 Degree of Competition
- 12.2.5 Threat of New Entrants
- 12.2.6 Threat of Substitutes
12.3 Value Chain Analysis